Literature DB >> 20209642

Characterization of cis elements of the probasin promoter necessary for prostate-specific gene expression.

JianFeng Zhang1, Nan Gao, David J DeGraff, Xiuping Yu, Qian Sun, Thomas C Case, Susan Kasper, Robert J Matusik.   

Abstract

BACKGROUND: The androgen-regulated probasin (PB) promoter has been used extensively to target transgenes to the prostate in transgenic mice; however, limited data exist on the mechanism that dictates prostate-specific gene expression. Tissue-specific gene expression involves synergistic effects among transcription factors associated in a complex bound to cis-acting DNA elements.
METHODS: Using comprehensive linker scan mutagenesis, enzyme mobility shift and supershift assays, chromatin immunoprecipitation, and transgenic animal studies, we have extensively characterized the prostate-specific PB promoter.
RESULTS: We identified a series of nonreceptor transcription factors that are bound to the prostate-specific rat PB promoter. These factors include several ubiquitously distributed proteins known to participate in steroid receptor-mediated transcription. In addition, we identified two tissue-specific DNA elements that are crucial in directing prostate-specific PB expression, and confirmed the functional importance of both elements in transgenic animal studies. These two elements are functionally interchangeable and can be bound by multiple protein complexes, including the forkhead transcription factor FoxA1, a "pioneer factor" that has a restricted distribution to some cells type that are ectoderm and endoderm in origin. Using transgenic mice, we further demonstrate that the minimal PB promoter region (-244/-96 bp) that encompasses these tissue-specific elements results in prostate-specific gene expression in transgenic mice, contains androgen receptor and FoxA1-binding sites, as well as ubiquitous transcription factor binding sites.
CONCLUSION: We propose that these sequence-specific DNA-binding proteins, including tissue-restricted and ubiquitous factors, create the first level of transcriptional control, which responds to intracellular pathways that directs prostate-specific gene expression.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20209642      PMCID: PMC3712623          DOI: 10.1002/pros.21128

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  51 in total

Review 1.  The Nuclear Factor I (NFI) gene family in mammary gland development and function.

Authors:  Janice Murtagh; Finian Martin; Richard M Gronostajski
Journal:  J Mammary Gland Biol Neoplasia       Date:  2003-04       Impact factor: 2.673

2.  Identification and characterization of a prostate-specific androgen-independent protein-binding site in the probasin promoter.

Authors:  Lillian H Y Yeung; Jason T Read; Pernille Sorenson; Colleen C Nelson; William Jia; Paul S Rennie
Journal:  Biochem J       Date:  2003-05-01       Impact factor: 3.857

Review 3.  Transcription regulation and animal diversity.

Authors:  Michael Levine; Robert Tjian
Journal:  Nature       Date:  2003-07-10       Impact factor: 49.962

4.  A small composite probasin promoter confers high levels of prostate-specific gene expression through regulation by androgens and glucocorticoids in vitro and in vivo.

Authors:  J Zhang; T Z Thomas; S Kasper; R J Matusik
Journal:  Endocrinology       Date:  2000-12       Impact factor: 4.736

5.  Hepsin promotes prostate cancer progression and metastasis.

Authors:  Olga Klezovitch; John Chevillet; Janni Mirosevich; Richard L Roberts; Robert J Matusik; Valeri Vasioukhin
Journal:  Cancer Cell       Date:  2004-08       Impact factor: 31.743

6.  Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei.

Authors:  J D Dignam; R M Lebovitz; R G Roeder
Journal:  Nucleic Acids Res       Date:  1983-03-11       Impact factor: 16.971

7.  The role of hepatocyte nuclear factor-3 alpha (Forkhead Box A1) and androgen receptor in transcriptional regulation of prostatic genes.

Authors:  Nan Gao; Jianfeng Zhang; Mira A Rao; Thomas C Case; Janni Mirosevich; Yongqing Wang; Renjie Jin; Aparna Gupta; Paul S Rennie; Robert J Matusik
Journal:  Mol Endocrinol       Date:  2003-05-15

8.  USF2 is connected to GAAAATATGATA element and associates with androgen receptor-dependent transcriptional regulation in prostate.

Authors:  Anne Kivinen; Lila Patrikainen; Riitta Kurkela; Katja Porvari; Pirkko Vihko
Journal:  Prostate       Date:  2004-05-01       Impact factor: 4.104

9.  Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer.

Authors:  Shunyou Wang; Jing Gao; Qunying Lei; Nora Rozengurt; Colin Pritchard; Jing Jiao; George V Thomas; Gang Li; Pradip Roy-Burman; Peter S Nelson; Xin Liu; Hong Wu
Journal:  Cancer Cell       Date:  2003-09       Impact factor: 31.743

10.  Myc-driven murine prostate cancer shares molecular features with human prostate tumors.

Authors:  Katharine Ellwood-Yen; Thomas G Graeber; John Wongvipat; M Luisa Iruela-Arispe; JianFeng Zhang; Robert Matusik; George V Thomas; Charles L Sawyers
Journal:  Cancer Cell       Date:  2003-09       Impact factor: 31.743

View more
  11 in total

1.  FOXA1 deletion in luminal epithelium causes prostatic hyperplasia and alteration of differentiated phenotype.

Authors:  David J DeGraff; Magdalena M Grabowska; Tom C Case; Xiuping Yu; Mary K Herrick; William J Hayward; Douglas W Strand; Justin M Cates; Simon W Hayward; Nan Gao; Michael A Walter; Ralph Buttyan; Yajun Yi; Klaus H Kaestner; Robert J Matusik
Journal:  Lab Invest       Date:  2014-05-19       Impact factor: 5.662

Review 2.  Modeling prostate cancer in mice: limitations and opportunities.

Authors:  Patrick J Hensley; Natasha Kyprianou
Journal:  J Androl       Date:  2011-06-16

3.  Androgen receptor antagonism by divalent ethisterone conjugates in castrate-resistant prostate cancer cells.

Authors:  Paul M Levine; Eugine Lee; Alex Greenfield; Richard Bonneau; Susan K Logan; Michael J Garabedian; Kent Kirshenbaum
Journal:  ACS Chem Biol       Date:  2012-08-07       Impact factor: 5.100

4.  Research Resource: Androgen Receptor Activity Is Regulated Through the Mobilization of Cell Surface Receptor Networks.

Authors:  Jordy J Hsiao; Brandon H Ng; Melinda M Smits; Harryl D Martinez; Rohini J Jasavala; Izumi V Hinkson; Damian Fermin; Jimmy K Eng; Alexey I Nesvizhskii; Michael E Wright
Journal:  Mol Endocrinol       Date:  2015-07-16

5.  NFI transcription factors interact with FOXA1 to regulate prostate-specific gene expression.

Authors:  Magdalena M Grabowska; Amicia D Elliott; David J DeGraff; Philip D Anderson; Govindaraj Anumanthan; Hironobu Yamashita; Qian Sun; David B Friedman; David L Hachey; Xiuping Yu; Jonathan H Sheehan; Jung-Mo Ahn; Ganesh V Raj; David W Piston; Richard M Gronostajski; Robert J Matusik
Journal:  Mol Endocrinol       Date:  2014-05-06

6.  Increased nuclear factor I/B expression in prostate cancer correlates with AR expression.

Authors:  Jagpreet S Nanda; Wisam N Awadallah; Sarah E Kohrt; Petra Popovics; Justin M M Cates; Janni Mirosevich; Peter E Clark; Giovanna A Giannico; Magdalena M Grabowska
Journal:  Prostate       Date:  2020-07-21       Impact factor: 4.104

7.  Nfib Regulates Transcriptional Networks That Control the Development of Prostatic Hyperplasia.

Authors:  Magdalena M Grabowska; Stephen M Kelly; Amy L Reese; Justin M Cates; Tom C Case; Jianghong Zhang; David J DeGraff; Douglas W Strand; Nicole L Miller; Peter E Clark; Simon W Hayward; Richard M Gronostajski; Philip D Anderson; Robert J Matusik
Journal:  Endocrinology       Date:  2015-12-17       Impact factor: 4.736

8.  Tumor Cell Autonomous RON Receptor Expression Promotes Prostate Cancer Growth Under Conditions of Androgen Deprivation.

Authors:  Nicholas E Brown; Andrew M Paluch; Madison A Nashu; Kakajan Komurov; Susan E Waltz
Journal:  Neoplasia       Date:  2018-08-15       Impact factor: 5.715

9.  Raddeanin A down-regulates androgen receptor and its splice variants in prostate cancer.

Authors:  Hongyan Xia; Cheng Hu; Shanshan Bai; Jing Lyu; Bryan Y Zhang; Xianghui Yu; Yang Zhan; Lijing Zhao; Yan Dong
Journal:  J Cell Mol Med       Date:  2019-03-23       Impact factor: 5.310

10.  Activation of GRP/GRP-R signaling contributes to castration-resistant prostate cancer progression.

Authors:  Jingbo Qiao; Magdalena M Grabowska; Ingrid S Forestier-Roman; Janni Mirosevich; Thomas C Case; Dai H Chung; Justin M M Cates; Robert J Matusik; H Charles Manning; Renjie Jin
Journal:  Oncotarget       Date:  2016-09-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.